FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

5 results

avycaz
(ceftazidime, avibactam)
Allergan, Inc.
Usage: AVYCAZ (ceftazidime and avibactam) is indicated for treating complicated intra-abdominal and urinary tract infections, including pyelonephritis, as well as hospital-acquired and ventilator-associated bacterial pneumonia. It targets susceptible gram-negative bacteria in adult and pediatric patients (≥31 weeks gestational age).
fetroja
(Cefiderocol sulfate tosylate)
Shionogi Inc.
Usage: FETROJA® is indicated for patients aged 18 and older for treating complicated urinary tract infections (cUTIs) including pyelonephritis, and hospital-acquired/ventilator-associated bacterial pneumonia, caused by susceptible Gram-negative bacteria like E. coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Use should limit drug resistance.
recarbrio
(imipenem anhydrous, cilastatin, and relebactam anhydrous)
Merck Sharp & Dohme LLC
Usage: RECARBRIO is indicated for treating adults with hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, complicated urinary tract infections, and complicated intra-abdominal infections caused by specific susceptible gram-negative bacteria, particularly when limited treatment options exist. Its use aims to combat drug-resistant bacterial development.
xacduro
(sulbactam and durlobactam)
LaJolla Pharmaceutical Company
Usage: XACDURO is indicated for treating hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) in adults, caused by susceptible strains of Acinetobacter baumannii-calcoaceticus. It should only be used for infections proven or suspected to be due to these bacteria to prevent drug resistance.
zerbaxa
(ceftolozane and tazobactam)
Merck Sharp & Dohme LLC
Usage: ZERBAXA is indicated for the treatment of complicated intra-abdominal infections, complicated urinary tract infections (including pyelonephritis), and hospital-acquired or ventilator-associated bacterial pneumonia in adults and pediatric patients, targeting specific susceptible Gram-negative and Gram-positive bacteria. Usage should be guided by culture results and epidemiology.

Medications for Hospital Acquired Bacterial Pneumonia

avycaz

fetroja

recarbrio

xacduro

zerbaxa